TABLE 2.
Patients for ChAG risk analysis | Patients for GC risk analysis | |||||
---|---|---|---|---|---|---|
Variable | NAG*† | ChAG*‡ | P value | NAG** | GC**§ | P value |
Subjects (n) | 86 | 43 | 133 | 133 | ||
Sex [male/female (%/%)] | 52/34 (60.5/39.5) | 26/17 (60.5/39.5) | 1.0 | 61/72 (45.9/54.1) | 61/72 (45.9/54.1) | 1.0 |
Mean age ± SD (y) | 64.0 (14.43) | 67.2 (12.73) | 0.85 | 61.4 (14.84) | 64.0 (14.76) | 0.2 |
H. pylori infection (%) | 88.4 | 76.7 | 0.12 | 88.0 | 74.4 | 0.006 |
Hospital | ||||||
Loyaza | 63 (73.3) | 28 (65.1) | 96 (72.2) | 80 (60.2) | ||
INEN | 23 (26.7) | 15 (34.9) | 0.41 | 37 (27.8) | 53 (39.8) | 0.052 |
Location | ||||||
Antrum | 61 (70.9) | 36 (83.7) | 95 (71.4) | 70 (52.6) | ||
Corpus | 25 (29.1) | 7 (16.3) | 0.09 | 38 (28.6) | 63 (47.4) | 0.002 |
Controls are matched 2:1
(1:1) to cases according age (± < 10 years), sex, and environmental risk factors.
Nonatrophic gastritis.
Chronic atrophic gastritis.
Gastric cancer.